Johnson & Johnson’s Sales Slide 11% During the Pandemic

Declines in medical devices and beauty products led the way

J&J's pharmaceutical unit proved resilient even during the pandemic. Getty Images

July 16, 2020

Johnson & Johnson’s worldwide year-over-year sales declined 10.8% in the second quarter of 2020, as fewer consumers had elective surgery or opted to buy beauty products during the pandemic.

Paul Hiebert

@hiebertpaul paul.hiebert@adweek.com Paul Hiebert is a CPG reporter at Adweek, where he focuses on data-driven stories that help illustrate changes in consumer behavior and sentiment.